KP Tissue Q1 FY26 net income rises to $2.2 million; Kruger Products adjusted EBITDA climbs 14.6% to $86.9 million
- KP Tissue posted Q1 2026 net income of $2.2 million, including $2.4 million as its share of Kruger Products’ net income.
- At Kruger Products, revenue edged down 0.3% to $544.6 million on an unfavorable foreign-exchange impact on U.S. dollar sales.
- Adjusted EBITDA climbed 14.6% to $86.9 million, with margin widening 1.6 percentage points to 16% on lower pulp prices and warehousing costs.
- Quarterly dividend increased to $0.21 per share, payable July 15, 2026, following a change in tax designation to non-eligible dividends.
- Management said demand remains healthy and production rates are exceeding targets; outlook calls for Q2 adjusted EBITDA to be in the range of Q1.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KP Tissue Inc. published the original content used to generate this news brief on May 14, 2026, and is solely responsible for the information contained therein.
